Table 1.
Demographic and clinical characteristics of study patients based on positivity for SARS-CoV-2
| Variable | All (n = 69) | SARS-CoV-2 RT-PCR |
P value | |
|---|---|---|---|---|
| Positive (n = 36) | Negative (n = 33) | |||
| Age, median (IQR) (years) | 64 (51–76) | 62.5 (51–75.25) | 65 (51–80) | – |
| Male | 34 (49%) | 19 (52%) | 15 (45%) | – |
| Female | 35 (51%) | 17 (47%) | 18 (55%) | – |
| BMI, median (IQR) (kg/m2) | 30 (26–35) | 30.5 (27–37) | 29 (24–33) | – |
| Black | 19 (28%) | 13 (36%) | 6 (18%) | – |
| White | 40 (58%) | 17 (47%) | 23 (70%) | – |
| Hispanic | 10 (14%) | 6 (17%) | 4 (12%) | – |
| Diabetes mellitus | 32 (46%) | 20 (56%) | 12 (36%) | – |
| Hypertension | 46 (67%) | 25 (69%) | 21 (64%) | – |
| COPD | 16 (23%) | 6 (17%) | 10 (30%) | – |
| Interstitial lung disease | 2 (3%) | 0 (0%) | 2 (6%) | – |
| Chronic kidney disease | 20 (29%) | 7 (19%) | 13 (39%) | – |
| Coronary artery disease | 15 (22%) | 7 (19%) | 8 (24%) | – |
| Symptom onset (IQR) | 3 (2–4.75) | 3 (2–5) | 4 (2–4.25) | – |
| Fever | 38 (55%) | 27 (75%) | 11 (33%) | – |
| Cough | 35 (51%) | 20 (56%) | 15 (45%) | – |
| Dyspnea | 60 (87%) | 32 (89%) | 28 (85% | – |
| Fatigue | 38 (55%) | 20 (56%) | 18 (55%) | – |
| Admitted to ICU | 37 (54%) | 24 (67%) | 13 (39%) | – |
| Mechanical ventilation | 18 (26%) | 11 (31%) | 7 (21%) | – |
| High-flow nasal cannula | 19 (28%) | 11 (31%) | 8 (24%) | – |
| Highest SOFA score, median (IQR) | 4 (2–6) | 5 (2–10) | 3 (2–4) | – |
BMI indicates body mass index; COPD, chronic obstructive pulmonary disease; ICU, intensive care unit; IQR, interquartile range; RT-PCR, reverse-transcription polymerase chain reaction; SOFA, sequential organ failure assessment.